Hi osi,
You are correct in that there will be an overlap , but the test has been found to be highly sensitive ( picks up true positives) and specific ( excludes true negatives)for a range of cancers. I had posted on the studies that have shown that. In conjunction with other known tests of breast cancer it improved the overall detection rate better than currently available tests. the next step will be to do exactly that, start validating midkine specific test for particular cancers and establish what they have found in initial trials a high detection rate and at same time ability to exclude false positives .
good luck
- Forums
- ASX - By Stock
- AN1
- fortune favours the brave
fortune favours the brave, page-26
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
AN1 (ASX) Chart |
Day chart unavailable